Galmed Pharma (GLMD) Prices 5.6M Share Offering at $1.25/sh Jul 14, 2023 09:31AM
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering Jul 14, 2023 09:30AM
Galmed Pharmaceuticals (GLMD) PT Lowered to $6 at Maxim Group, Following Earnings May 13, 2021 12:20PM
Galmed Pharma (GLMD) Prices 5M Share Common Offering at $15/Sh Jun 20, 2018 06:20AM
Galmed Pharmaceuticals Ltd. Announces Pricing of Public Offering of Ordinary Shares Jun 19, 2018 09:37PM


Jun 18, 2018 06:32AM Galmed Pharma (GLMD) Proposed $75M Public Offering of Ordinary Shares
Jun 18, 2018 06:30AM Galmed Pharmaceuticals Ltd. Announces Proposed Public Offering of Ordinary Shares
Jun 12, 2018 01:17PM Galmed Pharmaceuticals (GLMD) PT Raised to $30 at Maxim Group
Mar 15, 2018 09:27AM Pre-Open Movers 03/15: (SMRT) (RUBI) (CWAY) Higher; (SLDB) (JILL) (SPEX) Lower (more...)
Mar 15, 2018 09:17AM UPDATE: Maxim Group Upgrades Galmed Pharmaceuticals (GLMD) to Buy; Favorable Risk/Reward
Feb 14, 2018 09:06AM Maxim Group Downgrades Galmed Pharmaceuticals (GLMD) to Hold
Jul 31, 2017 09:34AM Galmed Pharmaceuticals (GLMD) PT Raised to $14 at Maxim Group
Mar 24, 2017 07:42AM Maxim Group Maintain Buy Rating and $9 PT on Galmed Pharma (GLMD) Following Q4 EPS Miss; 'Lack of N-T Catalysts'
Aug 1, 2016 08:51AM Galmed Pharmaceuticals (GLMD) PT Lowered to $9 at Maxim Group
Apr 6, 2016 01:11PM Galmed Pharma (GLMD) Surges 38%
Apr 4, 2016 12:17PM Streetinsider.com's Hot Lunchtime Reads 4/4: (ESI) (AAPL) (RKUS) (GLMD)
Apr 4, 2016 11:08AM Galmed Pharma (GLMD) May Be Worth $24/Share Based on Gilead's Nimbus Deal - Maxim Group
Sep 23, 2014 12:32PM Maxim Group Reiterats Bullish Stance on Galmed (GLMD) Following FDA Fast-Track Status; Funded Through Proof-of-Concept Studies in NASH
Apr 23, 2014 07:22AM Maxim Group Starts Galmed Pharmaceuticals (GLMD) at Buy, Sees Significant Upside
Mar 13, 2014 01:55PM Galmed Pharmaceuticals (GLMD) IPO Opens Higher, Trends Lower